May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Roota Hair Growth promotes fuller, healthier hair using plant-based ingredients and requires consistent use.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Roota Hair Growth promotes fuller, healthier hair using plant-based ingredients.
Removing silicone breast implants may improve symptoms of autoimmune/inflammatory syndrome.
May 2026 in “International Journal of Homoeopathic Sciences” Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.
April 2026 in “The Breast” Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.
February 2026 in “Advanced Science” Targeting the p300/AR axis may help treat polycystic ovary syndrome.
February 2026 in “Nature Synthesis” A new method creates unique chemical structures that could improve drug discovery.
January 2026 in “JAAD International” January 2026 in “European Journal of Cancer Care” Social support improves empowerment and quality of life for breast cancer patients with hair loss.
January 2026 in “Journal of Clinical and Investigative Dermatology” Verilich serum effectively and safely improves hair loss treatment.
December 2025 in “PubMed” The minoxidil and finasteride foam remains stable and effective for 180 days at room temperature.
November 2025 in “SKIN The Journal of Cutaneous Medicine” Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.
November 2025 in “SKIN The Journal of Cutaneous Medicine” Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.
November 2025 in “SKIN The Journal of Cutaneous Medicine” Baricitinib works better in adolescents than adults for treating severe alopecia areata.
Blocking autophagy worsens lipid buildup and dysfunction in brain cells after injury.
August 2025 in “International Journal of Molecular Sciences” Broccoli sprout extract may help regrow hair by improving hormone metabolism.
July 2025 in “Journal of Investigative Dermatology” Breezula® may be more effective than Minoxidil in promoting hair growth by reducing a hair growth inhibitor.
July 2025 in “International Journal of Dermatology” Safe alopecia treatments for breastfeeding women are limited due to potential risks to infants.
June 2025 in “Indian Journal of Veterinary Medicine” The dog's skin infection was cured with a new antibiotic treatment and supplements.
June 2025 in “British Journal of Dermatology” Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.
June 2025 in “British Journal of Dermatology” Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.
June 2025 in “CA A Cancer Journal for Clinicians” Transgender men need personalized cancer care and continued testosterone therapy for well-being.
June 2025 in “Annals of the Rheumatic Diseases” Brain fog in lupus is common, worrying, and often not treated properly.
April 2025 in “International Journal of Multidisciplinary Research in Science, Engineering and Technology.” Improved care and timely diagnosis are needed for women with PCOD and PCOS, and CystaCare can help.
April 2025 in “International Journal For Multidisciplinary Research” Hypertrichosis causes excessive hair growth and can be managed with treatments like laser, electrolysis, or new topical solutions.
April 2025 in “African Journal of Biomedical Research” Breast cancer patients undergoing chemotherapy often worry, lose weight, and cope by praying, meditating, or seeking support.
April 2025 in “Research Journal of Topical and Cosmetic Sciences” Bromelain in shampoo is a safe and effective anti-dandruff treatment that improves hair health and shine.
January 2025 in “International Journal of Women’s Dermatology” Dermatologists need better training on ethnic hair care to improve patient care and satisfaction.
January 2025 in “SKIN The Journal of Cutaneous Medicine” Baricitinib significantly regrows hair in severe alopecia areata patients.
January 2025 in “SKIN The Journal of Cutaneous Medicine” Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.